Article
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Jun 2023
Burgos Leire, Tamariz-Amador Luis-Esteban, Puig Noemi, Cedena Maria-Teresa, Guerrero Camila, Jelínek Tomas, Johnson Sarah, Milani Paolo, Cordon Lourdes, Perez Jose J, Lasa Marta, Termini Rosalinda, Oriol Albert, Hernandez Miguel-Teodoro, Palomera Luis, Martinez-Martinez Rafael, de la Rubia Javier, de Arriba Felipe, Rios Rafael, Gonzalez Maria-Esther, Gironella Mercedes, Cabañas Valentin, Casanova Maria, Krsnik Isabel, Perez-Montaña Albert, González-Calle Verónica, Rodriguez-Otero Paula, Maisnar Vladimir, Hajek Roman, Van Rhee Fritz, Jimenez-Zepeda Victor, Palladini Giovanni, Merlini Giampaolo, Orfao Alberto, de la Cruz Javier, Martinez-Lopez Joaquin, Lahuerta Juan-Jose, Rosiñol Laura, Blade Joan, Mateos Maria-Victoria, San-Miguel Jesus F, Paiva Bruno
Abstract excerpt
PURPOSE: The existence of patients with multiple myeloma (MM) and light-chain (AL) amyloidosis who present with a monoclonal gammopathy of undetermined significance (MGUS)-like phenotype has been hypothesized, but methods to identify this subgroup are not standardized and its clinical significance is not properly validated. PATIENTS AND METHODS: An algorithm to identify patients having MGUS-like phenotype was...
Read the complete abstract on PubMed